Magellan Health (MGLN) Stock Price, News & Analysis

Company Overview

Magellan Health, Inc. engages in the business of healthcare management. It operates through the following segments: Healthcare, Pharmacy Management and Corporate. The Healthcare segment includes the Behavioral & Specialty Health reporting unit, which provides carve-out management services for behavioral health, employee assistance plans, and other areas of specialty healthcare. The Pharmacy Management segment comprises of services that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit. The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Phoenix, AZ.

Key Stats

• Today's Range: $94.99 to $94.99
• 50-Day Range: $94.25 to $94.99
• 52-Week Range: $91.04 to $99.36
• Volume: N/A
• Average Volume: 238,670 shs
• Market Capitalization: $2.50 billion
• P/E Ratio: 8.28
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MGLN Stock Analysis - Frequently Asked Questions

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) released its earnings results on Friday, November, 5th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.37 by $0.34. The firm's revenue for the quarter was up 7.2% on a year-over-year basis.

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Magellan Health investors own include Energy Transfer (ET), Meta Platforms (META), Netflix (NFLX), UnitedHealth Group (UNH), Bristol-Myers Squibb (BMY), M&T Bank (MTB) and Broadcom (AVGO).

Company Calendar

• Last Earnings: 11/05/2021
• Today: 5/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Hospitals
• Sub-Industry: Managed Health Care
• Current Symbol: NASDAQ:MGLN
• CIK: 19411
• Web: www.magellanhealth.com
• Phone: (800) 642-1716
• Fax: 860-507-1990
• Employees: 9,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $11.47
• Trailing P/E Ratio: 8.28
• Forward P/E Ratio: 51.63
• P/E Growth: N/A
• Net Income: $382.33 million
• Net Margins: 6.26%
• Pretax Margin: -0.08%
• Return on Equity: 1.81%
• Return on Assets: 1.05%

Debt

• Debt-to-Equity Ratio: 0.27
• Current Ratio: 2.92
• Quick Ratio: 2.86

Sales & Book Value

• Annual Sales: $4.58 billion
• Price / Sales: 0.55
• Cash Flow: $5.57 per share
• Price / Cash Flow: 17.06
• Book Value: $73.03 per share
• Price / Book: 1.30

Miscellaneous

• Outstanding Shares: 26,332,000
• Free Float: 22,619,000
• Market Cap: $2.50 billion
• Optionable: Optionable
• Beta: 1.03